Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: Twelve-month results of the DENALI study

Peter K. Kaiser, David S. Boyer, Alan F. Cruess, Jason S. Slakter, Stefan Pilz, Annemarie Weisberger

Research output: Contribution to journal › Article › peer-review

117 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: Twelve-month results of the DENALI study'. Together they form a unique fingerprint.

Medicine & Life Sciences